Ha habido 50 transacciones internas recientes registradas para G1 Therapeutics, Inc. (GTHX), incluyendo 18 compras y 32 ventas. El total de compras internas fue valorado en $1.07M y el total de ventas internas en $3.42M.
Internos destacados con actividad reciente incluyen Muir Glenn P, Murdock Terry L, Secor Alicia. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — GTHX
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-09-18 |
Muir Glenn P |
Director |
Devolución de Acciones |
50,000 |
$0.30 |
$15K |
- |
| 2024-09-18 |
Murdock Terry L |
Chief Operating Officer |
Devolución de Acciones |
35,700 |
$5.73 |
$204.56K |
- |
| 2024-09-18 |
Secor Alicia |
Director |
OPA (Venta) |
10,000 |
- |
- |
- |
| 2024-09-18 |
Nicholson Garry A |
Director |
Devolución de Acciones |
30,000 |
$5.30 |
$159K |
- |
| 2024-09-18 |
Malik Rajesh |
Chief Medical Officer |
Devolución de Acciones |
74,500 |
$2.97 |
$221.27K |
- |
| 2024-09-18 |
Flowers Cynthia Louise |
Director |
Devolución de Acciones |
30,000 |
$5.30 |
$159K |
- |
| 2024-09-18 |
Avagliano Mark |
Chief Business Officer |
Devolución de Acciones |
41,100 |
$5.73 |
$235.5K |
- |
| 2024-09-18 |
Bailey John E. (jack) Jr. |
President and CEO |
Devolución de Acciones |
161,300 |
$5.73 |
$924.25K |
- |
| 2024-09-18 |
Perry Andrew |
Chief Commercial Officer |
Devolución de Acciones |
32,100 |
$5.73 |
$183.93K |
- |
| 2024-09-18 |
Lee Jacks |
Director |
Devolución de Acciones |
60,000 |
$5.35 |
$321K |
- |
| 2024-09-18 |
Sharpless Norman |
Director |
Devolución de Acciones |
30,000 |
$2.83 |
$84.9K |
- |
| 2024-09-18 |
Umstead John W. V |
Chief Financial Officer |
OPA (Venta) |
19,331 |
- |
- |
- |
| 2024-09-18 |
Thomas Monica R. |
Chief Legal & People Officer |
Devolución de Acciones |
150,000 |
$2.88 |
$432K |
- |
| 2024-07-05 |
Murdock Terry L |
Chief Operating Officer |
Venta Informativa |
2,475 |
$2.51 |
$6.21K |
128,012 |
| 2024-07-05 |
Malik Rajesh |
Chief Medical Officer |
Venta Informativa |
2,475 |
$2.51 |
$6.21K |
159,312 |
| 2024-07-05 |
Avagliano Mark |
Chief Business Officer |
Venta Informativa |
2,638 |
$2.51 |
$6.62K |
242,045 |
| 2024-07-05 |
Bailey John E. (jack) Jr. |
President and CEO |
Venta Informativa |
7,662 |
$2.51 |
$19.21K |
549,674 |
| 2024-07-05 |
Perry Andrew |
Chief Commercial Officer |
Venta Informativa |
1,337 |
$2.51 |
$3.35K |
112,614 |
| 2024-07-05 |
Umstead John W. V |
Chief Financial Officer |
Venta Informativa |
527 |
$2.51 |
$1.32K |
187,718 |
| 2024-07-01 |
Murdock Terry L |
Chief Operating Officer |
Concesión de RSU |
35,000 |
- |
- |
130,487 |
| 2024-07-01 |
Avagliano Mark |
Chief Business Officer |
Concesión de RSU |
35,000 |
- |
- |
244,683 |
| 2024-07-01 |
Bailey John E. (jack) Jr. |
President and CEO |
Concesión de RSU |
105,000 |
- |
- |
557,336 |
| 2024-07-01 |
Perry Andrew |
Chief Commercial Officer |
Concesión de RSU |
35,000 |
- |
- |
113,951 |
| 2024-07-01 |
Umstead John W. V |
Chief Financial Officer |
Concesión de RSU |
35,000 |
- |
- |
188,245 |
| 2024-07-01 |
Thomas Monica R. |
Chief Legal & People Officer |
Concesión de RSU |
35,000 |
- |
- |
144,825 |
| 2024-06-13 |
Muir Glenn P |
Director |
Concesión de RSU |
30,000 |
$2.99 |
$89.7K |
30,000 |
| 2024-06-13 |
Secor Alicia |
Director |
Concesión de RSU |
30,000 |
$2.99 |
$89.7K |
30,000 |
| 2024-06-13 |
Nicholson Garry A |
Director |
Concesión de RSU |
30,000 |
$2.99 |
$89.7K |
30,000 |
| 2024-06-13 |
Flowers Cynthia Louise |
Director |
Concesión de RSU |
30,000 |
$2.99 |
$89.7K |
30,000 |
| 2024-06-13 |
Lee Jacks |
Director |
Concesión de RSU |
10,000 |
- |
- |
20,000 |
| 2024-06-13 |
Sharpless Norman |
Director |
Concesión de RSU |
10,000 |
- |
- |
20,000 |
| 2024-05-23 |
Thomas Monica R. |
Chief Legal & People Officer |
Venta Informativa |
5,826 |
$4.27 |
$24.86K |
109,825 |
| 2024-05-13 |
Murdock Terry L |
Chief Operating Officer |
Venta Informativa |
8,151 |
$4.79 |
$39.03K |
95,487 |
| 2024-05-13 |
Malik Rajesh |
Chief Medical Officer |
Venta Informativa |
8,151 |
$4.79 |
$39.03K |
161,787 |
| 2024-05-13 |
Avagliano Mark |
Chief Business Officer |
Venta Informativa |
8,151 |
$4.79 |
$39.03K |
209,683 |
| 2024-05-13 |
Bailey John E. (jack) Jr. |
President and CEO |
Venta Informativa |
37,258 |
$4.79 |
$178.42K |
452,336 |
| 2024-05-13 |
Perry Andrew |
Chief Commercial Officer |
Venta Informativa |
8,151 |
$4.79 |
$39.03K |
78,951 |
| 2024-05-13 |
Umstead John W. V |
Chief Financial Officer |
Venta Informativa |
8,151 |
$4.79 |
$39.03K |
153,245 |
| 2024-03-20 |
Avagliano Mark |
Chief Business Officer |
Concesión de RSU |
100,000 |
- |
- |
217,834 |
| 2024-03-20 |
Umstead John W. V |
Chief Financial Officer |
Concesión de RSU |
37,500 |
- |
- |
161,396 |
| 2024-03-20 |
Thomas Monica R. |
General Counsel |
Concesión de RSU |
37,500 |
- |
- |
115,651 |
| 2024-03-18 |
Umstead John W. V |
Chief Financial Officer |
Venta Informativa |
6,547 |
$3.02 |
$19.75K |
123,896 |
| 2024-02-12 |
Malik Rajesh |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
28,600 |
$0.30 |
$8.58K |
- |
| 2024-01-04 |
Murdock Terry L |
Chief Operating Officer |
Venta Informativa |
721 |
$2.94 |
$2.12K |
103,638 |
| 2024-01-04 |
Malik Rajesh |
Chief Medical Officer |
Venta Informativa |
721 |
$2.94 |
$2.12K |
169,938 |
| 2024-01-04 |
Avagliano Mark |
Chief Business Officer |
Venta Informativa |
721 |
$2.94 |
$2.12K |
117,834 |
| 2024-01-04 |
Umstead John W. V |
Chief Financial Officer |
Venta Informativa |
111 |
$2.94 |
$326.60 |
130,443 |
| 2024-01-03 |
Murdock Terry L |
Chief Operating Officer |
Concesión de RSU |
74,500 |
$2.97 |
$221.27K |
74,500 |
| 2024-01-03 |
Malik Rajesh |
Chief Medical Officer |
Concesión de RSU |
74,500 |
$2.97 |
$221.27K |
74,500 |
| 2024-01-03 |
Avagliano Mark |
Chief Business Officer |
Concesión de RSU |
89,400 |
$2.97 |
$265.52K |
89,400 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
